Next Article in Journal
Home and Office Blood Pressure Control among Treated Hypertensive Patients in Japan: Findings from the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study
Next Article in Special Issue
Lambda Interferons: New Cytokines with Old Functions
Previous Article in Journal
Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates
Previous Article in Special Issue
Oromucosal Administration of Interferon to Humans

Deregulation of Interferon Signaling in Malignant Cells

Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Northwestern University Medical School and Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60611, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(2), 406-418;
Received: 10 December 2009 / Revised: 28 January 2010 / Accepted: 1 February 2010 / Published: 4 February 2010
(This article belongs to the Special Issue Interferons)
Interferons (IFNs) are a family of cytokines with potent antiproliferative, antiviral, and immunomodulatory properties. Much has been learned about IFNs and IFN-activated signaling cascades over the last 50 years. Due to their potent antitumor effects in vitro and in vivo, recombinant IFNs have been used extensively over the years, alone or in combination with other drugs, for the treatment of various malignancies. This review summarizes the current knowledge on IFN signaling components and pathways that are deregulated in human malignancies. The relevance of deregulation of IFN signaling pathways in defective innate immune surveillance and tumorigenesis are discussed. View Full-Text
Keywords: interferon; signaling pathways; cancer interferon; signaling pathways; cancer
Show Figures

Figure 1

MDPI and ACS Style

Katsoulidis, E.; Kaur, S.; Platanias, L.C. Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals 2010, 3, 406-418.

AMA Style

Katsoulidis E, Kaur S, Platanias LC. Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals. 2010; 3(2):406-418.

Chicago/Turabian Style

Katsoulidis, Efstratios, Surinder Kaur, and Leonidas C. Platanias 2010. "Deregulation of Interferon Signaling in Malignant Cells" Pharmaceuticals 3, no. 2: 406-418.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop